I am a
Home I AM A Search Login

Papers of the Week

Papers: 14 May 2022 - 20 May 2022

Pharmacology/Drug Development

2022 May 14

Curr Pain Headache Rep

CGRP Targeting Therapy for Chronic Migraine-Evidence from Clinical Trials and Real-world Studies.



Monoclonal antibodies against calcitonin gene-related peptide (CGRP) or its receptor have become part of the standard treatment for migraine in clinical practice. The current review focuses on the clinical evidence of CGRP monoclonal antibodies in patients with chronic migraine (CM), including more challenging cases.